ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ILMN Illumina Inc

104.30
3.25 (3.22%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 3,272,671
Bid Price 103.00
Ask Price 105.35
News -
Day High 104.35

Low
89.00

52 Week Range

High
213.1099

Day Low 100.76
Share Name Share Symbol Market Stock Type
Illumina Inc ILMN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
3.25 3.22% 104.30 19:00:00
Open Price Low Price High Price Close Price Previous Close
101.33 100.76 104.35 104.28 101.05
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
39,950 3,272,671 US$ 103.02 US$ 337,151,090 - 89.00 - 213.1099
Last Trade Type Quantity Price Currency
18:46:59 2 US$ 104.24 USD

Illumina (ILMN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-2M

Calls / Puts

6.25%

Buys / Sells

200.00%

OTM / ITM

6.25%

Sweeps Ratio

0.00%

Illumina Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
16.57B 158.90M - 4.5B -1.16B -7.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Illumina News

Date Time Source News Article
5/29/202408:15PR Newswire (US)Illumina drives genomic testing as standard of care in..
5/28/202415:05PR Newswire (US)Illumina releases 2023 Corporate Social Responsibility..
5/22/202416:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/22/202416:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
5/20/202415:27Edgar (US Regulatory)Form SD - Specialized disclosure report
5/20/202415:09Edgar (US Regulatory)Form 8-K - Current report
5/20/202415:05PR Newswire (US)Anna Richo joins Illumina's Board of Directors
5/17/202417:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/17/202417:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/17/202417:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/17/202417:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/17/202417:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ILMN Message Board. Create One! See More Posts on ILMN Message Board See More Message Board Posts

Historical ILMN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week106.69107.25100.085103.001,728,166-2.39-2.24%
1 Month127.08127.745100.085110.381,811,043-22.78-17.93%
3 Months137.23144.1899100.085121.851,634,723-32.93-24.00%
6 Months101.67148.1999.23128.631,866,2452.632.59%
1 Year194.51213.109989.00137.581,896,168-90.21-46.38%
3 Years410.49526.0089.00211.511,401,276-306.19-74.59%
5 Years308.03555.7789.00254.021,293,090-203.73-66.14%

Illumina Description

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.